Re-certified for CME credits, to Sept 6, 2020! The fourth activity in the Clinical Advances in Gene Therapy for Hemophilia CME curriculum, Why Gene Therapy for Hemophilia? Exploring the Challenges of Current Therapies, is an expert video exchange on gene therapy in the context of therapies currently available for hemophilia around the world. Watch as two expert hematologists, John Pasi (London, UK) and Johnny Mahlangu (Johannesburg, South Africa) consider the advantages, disadvantages, and unknowns of gene therapy in hemophilia, and the potential for this technology in countries with limited resources. A transcript of the discussion makes it easy for all learners to follow along, and presentation slides containing useful illustrations and key messages enhance the learning experience. Click the View Resource button to access the activity through the Medscape site. There you will have to register, which is free and straightforward.

This activity is part of the Clinical Advances in Gene Therapy for Hemophilia CME curriculum developed by the WFH in collaboration with the National Hemophilia Foundation (NHF), the European Haemophilia Consortium (EHC), and Medscape Education. These five online activities provide introductory information on gene therapy in hemophilia. While clinicians can qualify for CME credits all learners can obtain a completion certificate, or explore the activity to enhance their knowledge of gene therapy in hemophilia.

View the other activities in this curriculum:

• Self-assessment (survey): Test Your Knowledge of Gene Therapy in Hemophilia
• Expert round table discussion (video): Gene Therapy: Past, Present, and Future
• Expert commentary (video): The Science of Gene Therapy for Hemophilia
• Clinical column (article): Updates on Clinical Trials of Gene Therapy in Hemophilia